Since launching absorbable thread scaffolds in 2014, TESS delivers integrated solutions with scaffolds, exosomes, and polymer nanoscaffold injectables. TESSLIFT is a privately owned medical device company, dedicated to the development and commercialization of the world's first invented minimally invasive mesh implants. For research initiatives underway, we desire to use our novel technology to exp
and its use to meet other unmet clinical needs. With that in mind, we are closely cooperating with surgeons and biomedical engineers worldwide to maximize the safety and effectiveness of our products. The company's R&D model leads in collaborating with the top-notch global companies and government-funded institutions and defines the path to identifying and developing revolutionary ideas and innovations for patient care, the welfare of the consumers, and the environment around us. Our researchers and scientists have the freedom to stand at the forefront of translating ideas into products. our mission is to make continual dedication to shape the future of healthcare and biotechnology built on a commitment to helping address the world's most pressing issues and improve and save lives.
In a highly competitive marketplace, the success of a new product depends as much on the right distribution as on the formulation itself. tesslift specializes in developing a quality-assured distributorship to meet the most rigorous demands of professional and consumer healthcare and biotechnology. https://www.tesslift.com/about
